In particular, we identified NKD2, FOXQ1, and CEMIP as CTNB1-regulated genes, and the expression levels of these genes may be used as surrogate markers for indicating the activated Wnt/beta-catenin pathway in CRC tissues. This evidence concerns the gene FOXQ1 and colorectal carcinoma.